|Bid||247.62 x 800|
|Ask||254.19 x 1100|
|Day's Range||249.59 - 251.55|
|52 Week Range||219.50 - 284.97|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||44.74|
|Earnings Date||Aug 04, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||3.32 (1.38%)|
|Ex-Dividend Date||Jun 08, 2021|
|1y Target Est||277.60|
In this article, we will be looking at the 10 best dividend aristocrats to buy according to hedge funds. If you want to skip our detailed analysis of dividend aristocrats, and dividend investing, you can go directly to the 5 Best Dividend Aristocrats to Buy According to Hedge Funds. According to a report by Post […]
For the fourth time since May, jurors in federal court have found that C.R. Bard's IVC blood clot filter is defective and responsible for injuries and complications. The latest verdict for trial lawyers at Dallas-based Martin Baughman brings combined monetary awards to more than $7 million.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has taken a large step forward in transforming the patient experience through a vision of a "One-Stick Hospital Stay," building on its history of innovation and leadership in blood collection and vascular access solutions.